What is IDEXX Laboratories's forward P/E?

IDEXX Laboratories's forward P/E is 42.45: today's price over the analysts' average EPS estimate for the next twelve months, the earnings expected rather than those reported. By fiscal year, it trades at 47.2 times its FY2026 earnings and 41.8 times its FY2027 earnings.

What is IDEXX Laboratories's PEG ratio?

IDEXX Laboratories's PEG ratio is 3.47: its P/E of 47.49 over the 13.7% a year the analysts expect its earnings per share to grow from FY2025 to FY2030. Around 1 is often read as a P/E in line with the growth; above it, the price asks for more.

IDEXX Laboratories
D
Quotes are delayed by 15 minutes

IDXX

Arincen ScoreBeta86/100

86/100B

704.23

USD

7.22

(1.03%)

Market Open

Last updated: 13 Nov, 10:40 GMT-5 · Delayed 15 min

Fair value719.99Plus-2%498Price 704.231,107

Q4 FY2026 · Earnings report

EPS estimate 3.30Revenue estimate 1.18B

Q4 FY2026 · Earnings report

Monday 1 February

EPS estimate 3.30Revenue estimate 1.18B

Fair value719.99Plus-2%498Price 704.231,107

Q4 FY2026 · Earnings report

EPS estimate 3.30Revenue estimate 1.18B

Q4 FY2026 · Earnings report

Monday 1 February

EPS estimate 3.30Revenue estimate 1.18B

Overview Financials Forecast Earnings Company

IDEXX Laboratories P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.

IDEXX Laboratories's P/E ratio is 47.49: its share price of 704.23 over its earnings per share of 14.83 over the last twelve months.

Today: 47.49
Forward P/E, next 12 months: 42.45
PEG ratio: 3.47
Median, 5 years: 48.55
Low, 5 years: 33.59
High, 5 years: 74.63

P/E ratio = price ÷ EPS (last 12 months) = 704.23 ÷ 14.83 = 47.49

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is IDEXX Laboratories's P/E high compared with its own history?Is the P/E high or low for this stock? Today's P/E against every daily P/E of the stock's last 5 years, with the growth analysts expect: whether the stock is expensive or cheap compared with itself, and whether its growth explains it.

IDEXX Laboratories's P/E of 47.5 is around the middle of its 5-year range (33.6 to 74.6, median 48.5). It is in line with its own history.

5-year range of the daily P/E

Median 48.5

Today 47.5

33.6

74.6

The price against its P/E range

At its 5-year high P/E (74.6)At its median P/E (48.5)At its 5-year low P/E (33.6)Price

Each line is the earnings per share of the day times one P/E of the last five years: the price near the top line is near the most it was paid for those earnings, near the bottom line the least.

Growth a year: the past against what analysts expect

EPSSlower
Expected, to FY2028 13.6%Past 5 years 14.3%Past 3 years 17.7%
RevenueAbout the same
Expected, to FY2028 9.5%Past 5 years 9.7%Past 3 years 8.5%

	Past 5 years	Past 3 years	Expected, to FY2028	Expected against the past
EPS	14.3%	17.7%	13.6%	Slower
Revenue	9.7%	8.5%	9.5%	About the same

Buyers pay about the usual price for each point of growth: a PEG of 3.5 on expected growth against 3.4 on its median P/E and past five years' growth.

What changed in 5 years

Debt is lower than in FY2020: 0.6 times EBITDA against 1.3.
Buybacks: EPS grew ⁦14.3%⁩ a year since FY2020 against ⁦12.7%⁩ for net income; the falling share count added about 1.5 points a year.
Operating margin is higher than in FY2020: ⁦31.6%⁩ against ⁦25.7%⁩.
Unusual tax: FY2020 at ⁦12.1%⁩ against a usual ⁦20.0%⁩, which moves that year's profit and the P/E readings that include it.
Product grew from ⁦0.0%⁩ of revenue in FY2020 to ⁦59.0%⁩ in FY2025.
Since 15 November 2021 the price has changed ⁦+13.8%⁩: earnings per share ⁦+67.4%⁩ and the P/E ⁦−32.0%⁩.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal year	Period ending	P/E ratio	Forward P/E	Market cap	Net income
FY2027 · Estimate	31 Dec 2027	41.81	—	—	—
FY2026 · Estimate	31 Dec 2026	47.22	—	—	—
Today		47.49	42.45	55.48B	1.18B
FY2025	31 Dec 2025	51.15	45.37	54.19B	1.06B
FY2024	31 Dec 2024	38.40	31.98	34.10B	887.87M
FY2023	31 Dec 2023	54.56	53.11	46.11B	845.04M
FY2022	31 Dec 2022	50.24	41.39	34.11B	679.09M
FY2021	31 Dec 2021	75.32	83.31	56.10B	744.84M
FY2020	31 Dec 2020	73.28	59.65	42.66B	582.13M
FY2019	31 Dec 2019	52.57	42.80	22.49B	427.79M
FY2018	31 Dec 2018	42.86	39.12	16.16B	377.05M
FY2017	31 Dec 2017	52.13	37.20	13.73B	263.27M
FY2016	31 Dec 2016	47.39	37.20	10.52B	222.05M
FY2015	31 Dec 2015	35.14	30.68	6.75B	192.14M
FY2014	31 Dec 2014	40.78	36.07	7.42B	181.95M
FY2013	31 Dec 2013	30.11	33.03	5.65B	187.79M
FY2012	31 Dec 2012	28.62	28.12	5.10B	178.29M
FY2011	31 Dec 2011	27.02	26.55	4.37B	161.75M
FY2010	31 Dec 2010	28.27	28.60	3.99B	141.32M
FY2009	31 Dec 2009	25.72	26.73	3.14B	122.24M
FY2008	31 Dec 2008	18.62	23.13	2.16B	116.17M
FY2007	31 Dec 2007	38.39	35.75	3.61B	94.01M
FY2006	31 Dec 2006	26.61	26.83	2.49B	93.68M
FY2005	31 Dec 2005	29.91	34.61	2.34B	78.25M
FY2004	31 Dec 2004	23.84	26.25	1.87B	78.33M
FY2003	31 Dec 2003	27.78	25.15	1.59B	57.09M
FY2002	31 Dec 2002	24.33	24.15	1.10B	45.39M
FY2001	31 Dec 2001	25.23	23.76	949.18M	37.62M
FY2000	31 Dec 2000	20.76	21.16	760.63M	36.63M
FY1999	31 Dec 1999	18.97	16.13	618.44M	32.60M
FY1998	31 Dec 1998	—	32.04	1.02B	-15.20M
FY1997	31 Dec 1997	—	24.91	600.50M	-21.10M
FY1996	31 Dec 1996	20.45	150.00	666.82M	32.60M
FY1995	31 Dec 1995	36.18	—	777.97M	21.50M
FY1994	31 Dec 1994	21.43	—	285.00M	13.30M
FY1993	31 Dec 1993	25.68	—	249.07M	9.70M
FY1992	31 Dec 1992	22.20	—	108.80M	4.90M
FY1991	31 Dec 1991	17.38	—	55.62M	3.20M

Quarter	Period ending	P/E ratio	Forward P/E	Market cap	Net income
Q3 FY2026	30 Sept 2026	34.82	31.93	41.16B	1.18B
Q2 FY2026	30 Jun 2026	37.00	33.16	42.17B	1.14B
Q1 FY2026	31 Mar 2026	41.09	36.50	45.01B	1.10B
Q4 FY2025	31 Dec 2025	51.15	45.37	54.19B	1.06B
Q3 FY2025	30 Sept 2025	49.81	44.31	51.17B	1.03B
Q2 FY2025	30 Jun 2025	43.76	38.55	43.13B	985.66M
Q1 FY2025	31 Mar 2025	38.16	31.30	34.15B	894.97M
Q4 FY2024	31 Dec 2024	38.11	31.98	33.84B	887.87M
Q3 FY2024	30 Sept 2024	48.00	41.04	41.58B	866.24M
Q2 FY2024	30 Jun 2024	46.55	41.74	39.36B	845.63M
Q1 FY2024	31 Mar 2024	51.05	48.88	44.24B	866.57M
Q4 FY2023	31 Dec 2023	54.57	53.11	46.12B	845.04M
Q3 FY2023	30 Sept 2023	44.17	42.42	36.34B	822.73M
Q2 FY2023	30 Jun 2023	52.72	49.44	41.73B	791.44M
Q1 FY2023	31 Mar 2023	59.36	49.96	41.50B	699.18M
Q4 FY2022	31 Dec 2022	49.82	41.39	33.83B	679.09M
Q3 FY2022	30 Sept 2022	40.50	34.80	27.12B	669.65M
Q2 FY2022	30 Jun 2022	44.34	39.52	29.43B	663.89M
Q1 FY2022	31 Mar 2022	62.87	65.24	46.18B	734.52M
Q4 FY2021	31 Dec 2021	74.99	83.31	55.86B	744.84M
Q3 FY2021	30 Sept 2021	69.93	77.49	52.94B	757.03M
Q2 FY2021	30 Jun 2021	74.00	77.59	53.89B	728.17M
Q1 FY2021	31 Mar 2021	62.04	59.25	41.85B	674.56M
Q4 FY2020	31 Dec 2020	73.41	59.65	42.73B	582.13M
Q3 FY2020	30 Sept 2020	67.38	50.36	33.54B	497.72M
Q2 FY2020	30 Jun 2020	61.07	45.61	28.11B	460.23M
Q1 FY2020	31 Mar 2020	47.36	36.35	20.69B	436.94M
Q4 FY2019	31 Dec 2019	52.40	42.80	22.42B	427.79M
Q3 FY2019	30 Sept 2019	55.42	47.20	23.44B	422.93M
Q2 FY2019	30 Jun 2019	59.30	50.89	24.15B	407.30M
Q1 FY2019	31 Mar 2019	49.72	44.01	19.41B	390.28M
Q4 FY2018	31 Dec 2018	42.62	39.12	16.07B	377.05M
Q3 FY2018	30 Sept 2018	65.51	54.15	21.60B	329.66M
Q2 FY2018	30 Jun 2018	61.77	48.72	18.96B	306.96M
Q1 FY2018	31 Mar 2018	58.92	44.20	16.71B	283.69M
Q4 FY2017	31 Dec 2017	51.93	37.20	13.67B	263.27M
Q3 FY2017	30 Sept 2017	49.08	37.20	13.61B	277.35M
Q2 FY2017	30 Jun 2017	53.95	37.20	14.21B	263.29M
Q1 FY2017	31 Mar 2017	55.59	37.20	13.62B	245.09M
Q4 FY2016	31 Dec 2016	47.16	37.20	10.47B	222.05M
Q3 FY2016	30 Sept 2016	47.34	38.11	10.13B	214.07M
Q2 FY2016	30 Jun 2016	41.32	33.62	8.34B	201.85M
Q1 FY2016	31 Mar 2016	36.76	30.50	7.04B	191.58M
Q4 FY2015	31 Dec 2015	34.48	30.68	6.62B	192.14M
Q3 FY2015	30 Sept 2015	39.30	32.35	6.83B	173.70M
Q2 FY2015	30 Jun 2015	32.98	28.96	5.99B	181.63M
Q1 FY2015	31 Mar 2015	40.03	36.19	7.28B	181.94M
Q4 FY2014	31 Dec 2014	38.91	36.07	7.08B	181.95M
Q3 FY2014	30 Sept 2014	29.42	30.32	5.86B	199.24M
Q2 FY2014	30 Jun 2014	35.43	36.48	6.83B	192.77M
Q1 FY2014	31 Mar 2014	33.06	35.30	6.27B	189.52M
Q4 FY2013	31 Dec 2013	29.43	33.03	5.53B	187.79M
Q3 FY2013	30 Sept 2013	27.81	30.75	5.23B	187.92M
Q2 FY2013	30 Jun 2013	26.31	27.51	4.87B	185.10M
Q1 FY2013	31 Mar 2013	27.18	28.16	4.96B	182.42M
Q4 FY2012	31 Dec 2012	28.48	28.12	5.08B	178.29M
Q3 FY2012	30 Sept 2012	31.03	31.08	5.37B	172.93M
Q2 FY2012	30 Jun 2012	31.41	31.04	5.29B	168.55M
Q1 FY2012	31 Mar 2012	29.10	29.17	4.83B	165.88M
Q4 FY2011	31 Dec 2011	26.27	26.55	4.25B	161.75M
Q3 FY2011	30 Sept 2011	24.42	24.82	3.91B	160.14M
Q2 FY2011	30 Jun 2011	28.41	29.18	4.44B	156.36M
Q1 FY2011	31 Mar 2011	30.62	30.42	4.44B	144.90M
Q4 FY2010	31 Dec 2010	28.14	28.60	3.98B	141.32M
Q3 FY2010	30 Sept 2010	26.17	26.67	3.56B	135.90M
Q2 FY2010	30 Jun 2010	26.50	27.58	3.52B	132.72M
Q1 FY2010	31 Mar 2010	25.85	27.36	3.34B	129.19M
Q4 FY2009	31 Dec 2009	25.38	26.73	3.10B	122.24M
Q3 FY2009	30 Sept 2009	25.54	26.47	2.93B	114.83M
Q2 FY2009	30 Jun 2009	24.97	25.98	2.72B	108.99M
Q1 FY2009	31 Mar 2009	17.84	20.73	2.05B	114.69M
Q4 FY2008	31 Dec 2008	18.38	23.13	2.13B	116.17M
Q3 FY2008	30 Sept 2008	27.59	34.68	3.26B	118.14M
Q2 FY2008	30 Jun 2008	24.75	30.46	2.93B	118.24M
Q1 FY2008	31 Mar 2008	29.82	30.40	3.00B	100.54M
Q4 FY2007	31 Dec 2007	37.96	35.75	3.57B	94.01M
Q3 FY2007	30 Sept 2007	35.22	34.27	3.28B	93.16M
Q2 FY2007	30 Jun 2007	31.62	30.35	2.92B	92.32M
Q1 FY2007	31 Mar 2007	28.29	28.84	2.73B	96.43M
Q4 FY2006	31 Dec 2006	26.36	26.83	2.47B	93.68M
Q3 FY2006	30 Sept 2006	31.95	33.31	2.84B	89.03M
Q2 FY2006	30 Jun 2006	27.92	29.86	2.36B	84.68M
Q1 FY2006	31 Mar 2006	34.83	37.60	2.75B	78.84M
Q4 FY2005	31 Dec 2005	29.25	34.61	2.29B	78.25M
Q3 FY2005	30 Sept 2005	28.90	32.15	2.17B	75.16M
Q2 FY2005	30 Jun 2005	27.39	29.97	2.03B	74.25M
Q1 FY2005	31 Mar 2005	22.82	26.04	1.78B	78.23M
Q4 FY2004	31 Dec 2004	22.97	26.25	1.80B	78.33M
Q3 FY2004	30 Sept 2004	23.42	25.12	1.73B	73.76M
Q2 FY2004	30 Jun 2004	31.08	32.13	2.18B	70.04M
Q1 FY2004	31 Mar 2004	31.48	29.94	1.98B	62.82M
Q4 FY2003	31 Dec 2003	28.18	25.15	1.61B	57.09M
Q3 FY2003	30 Sept 2003	25.47	24.75	1.46B	57.48M
Q2 FY2003	30 Jun 2003	21.05	20.86	1.14B	53.99M
Q1 FY2003	31 Mar 2003	23.52	23.65	1.18B	50.27M
Q4 FY2002	31 Dec 2002	24.24	24.15	1.10B	45.39M
Q3 FY2002	30 Sept 2002	24.27	23.45	1.03B	42.46M
Q2 FY2002	30 Jun 2002	21.20	20.17	852.29M	40.19M
Q1 FY2002	31 Mar 2002	25.18	21.68	936.53M	37.20M
Q4 FY2001	31 Dec 2001	25.68	23.76	966.00M	37.62M
Q3 FY2001	30 Sept 2001	20.84	20.17	783.41M	37.59M
Q2 FY2001	30 Jun 2001	28.33	27.93	1.04B	36.65M
Q1 FY2001	31 Mar 2001	20.04	20.33	725.75M	36.21M
Q4 FY2000	31 Dec 2000	19.87	21.16	727.82M	36.63M
Q3 FY2000	30 Sept 2000	25.70	25.98	918.32M	35.73M
Q2 FY2000	30 Jun 2000	23.16	22.43	807.23M	34.86M
Q1 FY2000	31 Mar 2000	24.43	23.08	814.32M	33.33M
Q4 FY1999	31 Dec 1999	17.28	16.13	563.25M	32.60M
Q3 FY1999	30 Sept 1999	—	17.94	657.44M	-6.40M
Q2 FY1999	30 Jun 1999	—	25.36	932.50M	-8.80M
Q1 FY1999	31 Mar 1999	—	27.22	919.70M	-11.70M
Q4 FY1998	31 Dec 1998	—	32.04	1.03B	-15.20M
Q3 FY1998	30 Sept 1998	75.87	30.24	895.31M	11.80M
Q2 FY1998	30 Jun 1998	—	33.66	975.87M	-11.00M
Q1 FY1998	31 Mar 1998	—	26.11	684.00M	-18.20M
Q4 FY1997	31 Dec 1997	—	24.91	605.63M	-21.10M
Q3 FY1997	30 Sept 1997	—	32.91	643.35M	-8.80M
Q2 FY1997	30 Jun 1997	31.66	32.92	522.38M	16.50M
Q1 FY1997	31 Mar 1997	23.77	56.40	630.00M	26.50M
Q4 FY1996	31 Dec 1996	24.85	150.00	810.00M	32.60M
Q3 FY1996	30 Sept 1996	29.02	—	885.02M	30.50M
Q2 FY1996	30 Jun 1996	28.14	—	771.04M	27.40M
Q1 FY1996	31 Mar 1996	35.11	—	860.22M	24.50M
Q4 FY1995	31 Dec 1995	36.92	—	793.80M	21.50M
Q3 FY1995	30 Sept 1995	33.64	—	629.10M	18.70M
Q2 FY1995	30 Jun 1995	25.13	—	424.67M	16.90M
Q1 FY1995	31 Mar 1995	23.82	—	345.33M	14.50M
Q4 FY1994	31 Dec 1994	22.15	—	294.55M	13.30M
Q3 FY1994	30 Sept 1994	18.97	—	240.87M	12.70M
Q2 FY1994	30 Jun 1994	20.67	—	241.80M	11.70M
Q1 FY1994	31 Mar 1994	18.95	—	210.31M	11.10M
Q4 FY1993	31 Dec 1993	26.67	—	258.70M	9.70M
Q3 FY1993	30 Sept 1993	25.83	—	198.90M	7.70M
Q2 FY1993	30 Jun 1993	22.36	—	147.60M	6.60M
Q1 FY1993	31 Mar 1993	21.24	—	123.20M	5.80M
Q4 FY1992	31 Dec 1992	20.82	—	102.00M	4.90M
Q3 FY1992	30 Sept 1992	18.06	—	81.25M	4.50M
Q2 FY1992	30 Jun 1992	20.86	—	83.44M	4.00M
Q1 FY1992	31 Mar 1992	18.84	—	64.06M	3.40M
Q4 FY1991	31 Dec 1991	17.38	—	55.62M	3.20M
Q3 FY1991	30 Sept 1991	—	—	44.69M	—
Q2 FY1991	30 Jun 1991	—	—	27.89M	—
Q1 FY1991	31 Mar 1991	—	—	35.53M	—

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

Common questions about IDEXX Laboratories's P/E ratio

Source: Financial Modeling Prep

IDEXX Laboratories
D
Quotes are delayed by 15 minutes

IDXX

IDEXX Laboratories P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.

Is IDEXX Laboratories's P/E high compared with its own history?Is the P/E high or low for this stock? Today's P/E against every daily P/E of the stock's last 5 years, with the growth analysts expect: whether the stock is expensive or cheap compared with itself, and whether its growth explains it.

The price against its P/E range

Growth a year: the past against what analysts expect

What changed in 5 years

P/E ratio by year and by quarter

Common questions about IDEXX Laboratories's P/E ratio

What is IDEXX Laboratories's P/E ratio?

Is IDEXX Laboratories's P/E ratio high or low?

What is IDEXX Laboratories's forward P/E?

What is IDEXX Laboratories's PEG ratio?

Need help?

IDEXX Laboratories DQuotes are delayed by 15 minutes

IDXX

IDEXX Laboratories P/E ratioWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.

Is IDEXX Laboratories's P/E high compared with its own history?Is the P/E high or low for this stock? Today's P/E against every daily P/E of the stock's last 5 years, with the growth analysts expect: whether the stock is expensive or cheap compared with itself, and whether its growth explains it.

P/E ratio by year and by quarter

Common questions about IDEXX Laboratories's P/E ratio

What is IDEXX Laboratories's P/E ratio?

Is IDEXX Laboratories's P/E ratio high or low?

What is IDEXX Laboratories's forward P/E?

What is IDEXX Laboratories's PEG ratio?

Need help?

IDEXX Laboratories
D
Quotes are delayed by 15 minutes